Avidity Biosciences vs Orchard Therapeutics
Avidity Biosciences vs Orchard Therapeutics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Avidity Biosciences is on 53/100 and Orchard Therapeutics on 51/100.
Where each one leads
Avidity Biosciences
- headcount: 445 against 248
- funding raised: $495M against $125M
Orchard Therapeutics
- domain rating: 60/100 against 46/100
- LinkedIn following: 54,964 against 37,705
At a glance
| Measure | Avidity Biosciences | Orchard Therapeutics |
|---|---|---|
| What it is | Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases. | Gene therapy company developing treatments for rare inherited diseases. |
| Category | Biotech, Drug Discovery, Genomics, Clinical Trials | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2013 | 2015 |
| Headquarters | San Diego, United States | Boston, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Avidity Biosciences | Orchard Therapeutics |
|---|---|---|
| Employees | 445 | 248 |
| Total funding | $495M | $125M |
| Latest round | IPO | IPO |
| LinkedIn followers | 37,705 | 54,964 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Avidity Biosciences | Orchard Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 51/100 |
| Traction | 60/100 | 60/100 |
| Team | Not published | 30/100 |
| Search visibility | 22/100 | 25/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (37/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 60/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Avidity Biosciences | Orchard Therapeutics |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery |
| Analytics | Google Tag Manager | Google Tag Manager |
Avidity Biosciences vs Orchard Therapeutics: common questions
Which is better, Avidity Biosciences or Orchard Therapeutics?
On our 0-100 score Avidity Biosciences rates higher (53/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Avidity Biosciences and Orchard Therapeutics compare on the numbers?
Avidity Biosciences leads on headcount (445 against 248), funding raised ($495M against $125M). Orchard Therapeutics leads on domain rating (60/100 against 46/100), LinkedIn following (54,964 against 37,705).
Read the full Avidity Biosciences review and pricing or the Orchard Therapeutics review and pricing. You can also browse other Avidity Biosciences alternatives we track.